Second Sight AMD

Doctors are always looking for ways that they can improve the lives and health of their patients, including research studies. Below are details of a study currently looking for volunteers.  Please use the contact details at the end of the page for more information.

What is the aim of the study?

To evaluate the safety and benefit of the Argus II System in a selected outer retinal degeneration population with late stage dry age‐related macular degeneration (AMD) that is severely affecting central vision

The Argus II Retinal Prosthesis System is intended to provide electrical stimulation of the retina and will take place at the NIHR/Wellcome Trust Manchester Clinical Research Facility.

Further information on this study is listed on the Second Sight website.

How can I get involved?

Please contact Ellie Ridyard, Clinical Trials Co-ordinator, / +44 (0)161 701 7691 at the Royal Manchester Eye Hospital for more information.